Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression
“If the results are confirmed in subsequent studies … antidepressants may no longer need to be stopped for psilocybin treatment,” says MindMed Executive President Dr. Miri Halperin Wernli.
Mindset Pharma’s DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge
“The data suggests that we have a new drug that may be at least as effective, if not more effective, than 5-MeO-DMT and, more importantly, it looks like it is much safer,” says Mindset Pharma CEO James Lanthier.
Heroic Hearts Project Connects Military Veterans with Psychedelic Therapy
On an improvised 70-mile marathon through the Andes Mountains of…
Can Wearable Technology Help Alleviate Stress?
Can wearable technology help alleviate stress? Apollo Neuro’s new wearable shows amazing promise
The Art of Medicinal Mushrooms Extraction: A Comprehensive Guide to Nature’s Powerful Remedies
Unveiling the fascinating art of medicinal mushrooms extraction, shedding light on this nuanced process and its importance in harnessing the potent health benefits of medicinal mushrooms.
What is Seasonal Affective Disorder (SAD) and How to Treat It?
In the winter months, a small percentage of the population falls victim to Seasonal Affective Disorder (SAD), which causes symptoms of depression for up to 40% of the year. In this article, we will discuss SAD and provide tips on how to manage it.